A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Study Identifier
P11-282
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Recruitment Complete
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18 - 99 Years
Protocol Summary
This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.
Study Locations
Location
Status
Location
Birmingham Gastroenterology Associates P.C /ID# 102063
Birmingham, Alabama, United States, 35209
Status
Not applicable
Location
University of Alabama at Birmingham - Main /ID# 131646
Birmingham, Alabama, United States, 35233
Status
Not applicable
Location
Longwood Research /ID# 118662
Huntsville, Alabama, United States, 35801
Status
Not applicable
Location
East View Medical Research, LLC /ID# 116259
Mobile, Alabama, United States, 36606
Status
Not applicable
Location
Mobile Medical & Diagnostic Center, AL /ID# 102064
Mobile, Alabama, United States, 36617
Status
Not applicable
Location
HOPE Research Institute /ID# 127947
Phoenix, Arizona, United States, 85018
Status
Not applicable
Showing {first} - {last} of {total} Results